Clinical trial
A Prospective, Multicenter, Objective Performance Criteria-Controlled Study for National Medical Products Administration Approval Of The Thoracic Aortic Stent Graft System
NCT05430672 is registered in ClinicalTrials.gov with Zhejiang Zylox Medical Device Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Multicenter, Objective Performance Criteria-Controlled Study for National Medical Products Administration Approval Of The Thoracic Aortic Stent Graft System
- Lead sponsor
- Zhejiang Zylox Medical Device Co., Ltd.
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2022
- Completion date
- August 31, 2024
- Enrollment
- 120 (estimated)
- Sites
- 14
Conditions
As the registry lists them; a condition with its own page is linked.